Quoin Pharmaceuticals (QNRX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Quoin Pharmaceuticals (QNRX) is Moderate Underperform.

The composite score behind that read is -0.42, weighing +1.00 of bullish evidence against -0.44 bearish.

Quoin Pharmaceuticals last closed at $4.70, -0.42% on the session.

Against the IVW growth benchmark the position is -0.26% over the forecast window.

The read is built from 11 underlying insights — 1 bullish and 10 bearish.

Agreement across those insights is 91%.

18 graded predictions for QNRX so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Quoin Pharmaceuticals in the 3rd percentile on return on equity, where 100 is best.

Quoin Pharmaceuticals is classified under Health Care / Biotechnology, with a market capitalisation of $22.67M.

StockMap tracks Quoin Pharmaceuticals as the 331st largest of the 377 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 198 Moderate Underperform, 166 Neutral and 13 Strong Underperform.

On that composite Quoin Pharmaceuticals ranks 347th of 377 in the group, against a group median of -0.21.